By monitoring serial changes in an individual’s CA125 levels over time, ROCA demonstrated an increased cancer detection rate compared to a simple single-threshold rule in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) [13]. The gene discussed is MUC16; the disease is cancer.